Brief: Oragenics Provides Update On Terra CoV-2 vaccine against SARS-CoV-2
14/01/2021 12:23
Jan 14 (Reuters) - Oragenics Inc OGEN.A :
* ORAGENICS - PROVIDES UPDATE ON COMPETITIVE POSITIONING OF
TERRA
COV-2 VACCINE AGAINST SARS-COV-2, EXPECTS TO FILE IND IN 3Q21
Source text for Eikon: ID:nBw6hz611a
Further company coverage: OGEN.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oragenics
See all newsBrief: Oragenics Reports Continued Clinical Progress, Provides Regulatory And NYSE American Listing Update
Brief: Oragenics Signs Letter Of Intent To License Cardiodialysis™ Technology From Sigyn Therapeutics To Target Tbi-Induced Systemic Inflammation
Brief: Oragenics Inc - Signs Letter Of Intent To License Cardiodialysis From Sigyn Therapeutics - SEC Filing
Brief: Oragenics Activates Second Site In Phase Iia Clinical Trial Of Onp-002 For Concussion And Mild Traumatic Brain Injury.
Brief: Oragenics Enters Settlement Agreement With Ladenburg Thalmann - Sec Filing